Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

51.68 +1.77 (+3.55%)

Streaming Delayed Price Updated: 2:50 PM EDT, Jun 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Discover which S&P500 stocks are making waves on Wednesday. ↗

March 05, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗

March 05, 2025

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80% ↗

March 04, 2025

Via The Motley Fool

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

March 04, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers.

Via StockStory

Topics Artificial Intelligence

Moderna Unusual Options Activity ↗

February 28, 2025

Via Benzinga

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

February 28, 2025

Via ACCESS Newswire

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock? ↗

February 27, 2025

Via The Motley Fool

1 Healthcare Stock to Own for Decades and 2 to Ignore

February 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. ↗

February 28, 2025

Via The Motley Fool

Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines ↗

February 28, 2025

The stock fell over 7% on Thursday after reports that federal health officials under the Trump administration are re-evaluating Moderna's $590 million contract for bird flu vaccine development.

Via Stocktwits

Topics Government

Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds ↗

February 27, 2025

Moderna is under pressure as two of its vaccines hit potential snags.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Behind the Scenes of Moderna's Latest Options Trends ↗

February 26, 2025

Via Benzinga

Moderna to Present at Upcoming Conferences in March 2025

February 25, 2025

Via ACCESS Newswire

Gapping S&P500 stocks in Thursday's session ↗

February 27, 2025

Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session.

Via Chartmill

Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗

February 27, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Trump's Officials To Re-Consider Moderna's $590 Million Bird Flu Vaccine Funding: RFK Jr-Led HHS Slams 'Biden Administration's Failed Oversight' ↗

February 27, 2025

The Donald Trump administration is contemplating the withdrawal of a $590 million contract previously granted to Moderna Inc. (NASDAQ: MRNA) by the Biden administration. This contract was intended for...

Via Benzinga

Topics Government

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 24, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

February 24, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Which S&P500 stocks are gapping on Monday? ↗

February 24, 2025

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends.

Via Chartmill

Bill Gates Says 'Next Pandemic Can Emerge Anywhere' And The World Isn't Prepared: 'We Can't Afford To Get Caught Flat-Footed Again' ↗

February 24, 2025

Via Benzinga

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

Market Monitor February 24th ↗

February 24, 2025

Wall Street Slumps Amid Consumer Worries and New Virus Concerns from China

Via Chartmill

10 Worst Performing Large-Caps Last 12 Months ↗

February 23, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. ↗

February 20, 2025

Via The Motley Fool

Moderna: A Generational Opportunity for Investors in 2025

February 19, 2025

Moderna had a weak quarter but reaffirmed guidance, expecting three new product approvals in 2025 and as many as ten more within three years.

Via MarketBeat

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 18, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Moderna (MRNA) Stock Is Up Today

February 18, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 financial results....

Via StockStory

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday ↗

February 18, 2025

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.